CANTON, Mass. (AP) — CANTON, Mass. (AP) — Organogenesis Holdings Inc. (ORGO) on Thursday reported profit of $7.7 million in its fourth quarter.
On a per-share basis, the Canton, Massachusetts-based company said it had net income of 4 cents.
The regenerative medicine company posted revenue of $126.7 million in the period.
For the year, the company reported profit of $861,000, or 1 cent per share. Revenue was reported as $482 million.
Organogenesis expects full-year revenue in the range of $480 million to $535 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORGO at https://www.zacks.com/ap/ORGO
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
